Comparison between Dishman Pharmaceuticals Chemicals IPO and ICICI Bank FPO.
Dishman Pharmaceuticals Chemicals IPO is a Mainboard Bookbuilding IPO proposed to list at BSE, NSE while ICICI Bank FPO is a Mainboard Bookbuilding proposed to list at BSE, NSE.
The total issue size of Dishman Pharmaceuticals Chemicals IPO is up to ₹60.09 Cr whereas the issue size of the ICICI Bank FPO is up to ₹5,750.00 Cr. The final issue price of Dishman Pharmaceuticals Chemicals IPO is ₹175.00 per share and of ICICI Bank FPO is ₹525.00 per share.
| Dishman Pharmaceuticals Chemicals IPO | ICICI Bank FPO | |
|---|---|---|
| Face Value | ₹10 per share | ₹10 per share |
| Issue Price (Lower) | ₹155.00 per share | ₹505.00 per share |
| Issue Price (Upper) | ₹175.00 per share | ₹545.00 per share |
| Issue Price (Final) | ₹175.00 per share | ₹525.00 per share |
| Discount (Retail) | ₹26.25 per share | |
| Discount (Employee) | ||
| Market Lot Size | ||
| Fresh Issue Size | 34,33,500 shares | 11,09,68,586 shares |
| Fresh Issue Size (Amount) | up to ₹60.09 Cr | up to ₹5,750.00 Cr |
| OFS Issue Size | 0 shares | 0 shares |
| OFS Issue Size (Amount) | up to ₹0.00 Cr | up to ₹0.00 Cr |
| Issue Size Total | 34,33,500 shares | 11,09,68,586 shares |
| Issue Size Total (Amount) | up to ₹60.09 Cr | up to ₹5,750.00 Cr |
Dishman Pharmaceuticals Chemicals IPO opens on Mar 29, 2004, while ICICI Bank FPO opens on Dec 01, 2005. The closing date of Dishman Pharmaceuticals Chemicals IPO and ICICI Bank FPO is Apr 07, 2004, and Dec 06, 2005, respectively.
Dishman Pharmaceuticals Chemicals IPO P/E ratio is 12.64, as compared to ICICI Bank FPO P/E ratio of .
| Dishman Pharmaceuticals Chemicals IPO | ICICI Bank FPO | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Financials | Company Financials (Restated Consolidated)
| Company Financials (Restated Consolidated)
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Pre-Issue) | 99.994 | 0 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Post-Issue) | 74.99 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| P/E Ratio | 12.64 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Market Cap | ₹240.34 Cr. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROE | 17.9 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROCE | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Debt/Equity | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| EPS | ₹13.84 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| RoNW | 30.74 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
In the Dishman Pharmaceuticals Chemicals IPO Retail Individual Investors (RII) are offered 8,58,400 shares while in ICICI Bank FPO retail investors are offered 8,58,400 shares. Qualified Institutional Buyers (QIB) are offered 17,16,700 shares in Dishman Pharmaceuticals Chemicals IPO and 5,32,14,286 shares in ICICI Bank FPO.
| Dishman Pharmaceuticals Chemicals IPO | ICICI Bank FPO | |
|---|---|---|
| Anchor Investor Reservation | 0 shares | 0 shares |
| Market Maker Reservation | 0 shares | 0 shares |
| QIB | 17,16,700 shares | 5,32,14,286 shares |
| NII | 8,58,400 shares | 1,59,64,285 shares |
| RII | 8,58,400 shares | 3,72,50,000 shares |
| Employee | 0 shares | 0 shares |
| Others | ||
| Total | 34,33,500 shares | 11,14,41,102 shares |
Dishman Pharmaceuticals Chemicals IPO subscribed in total, whereas ICICI Bank FPO subscribed .
